ConductScience.org, home

Trial · NCT07887256

Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE Study

NCT07887256, Not yet recruiting, Leiden University Medical Center

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE Study. Trials, record NCT07887256. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887256

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE Study
NCT number
NCT07887256
Status
Not yet recruiting
Enrollment
100 participants, estimated
Lead sponsor
Leiden University Medical Center
Conditions
Reconstructive Surgery, Flap Monitoring
Interventions
Elective free flap surgery, INVOS monitoring
First posted
2026-10-21
Last updated
2026-10-21

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProportion successfully maintained monitorFrom day of surgery (day 0) until day 3 postoperativeThe proportion of patients (%) in whom continuous tissue oximetry monitoring was successfully maintained for the entire postoperative period.
SecondarySurgical re-explorationFrom day of surgery (day 0) until day 3 postoperativeSurgical re-exploration performed because of suspected vascular compromise of the free flap. Yes/no.
SecondaryFlap failureFrom day of surgery (day 0) until day 3 postoperativeFlap failure. Yes/no.
SecondaryFlap risk scoreFrom day of surgery (day 0) until day 3 posteroperative
0= no risk parameters present 6= all risk parameters present. Risk parameters are: color, consistency, capillary refill, temperature, doppler signal, clinical suspiscion. Parameters score 0 if the parameter is clinically judged to be normal/optimal and 1 if parameter is clinically judged to be suboptimal
SecondaryPostoperative complicationsFrom day of surgery (day 0) until day 3 posteroperative
According to Clavien-Dindo scale Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included. Grade III Requiring surgical, endoscopic or radiological intervention * IIIa Intervention not under general anesthesia * IIIb Intervention under general anesthesia Grade IV Life-threatening complication (including CNS complications)\* requiring IC/ICU-management * IVa single organ dysfunction (including dialysis) * IVb multiorgandysfunction Grade V Death of a patient
SecondaryINVOS risk triggers: absolute drop of StO₂From start of INVOS measurements (day 0) until day 3 postoperativeNumber of absolute drops of StO₂ \< 60%.
SecondaryINVOS risk triggers: relative drop StO₂From start of INVOS measurements (day 0) until day 3 postoperativeNumber of relative drops of StO₂ ≥20% decrease from baseline sustained ≥30 minutes.
SecondaryINVOS risk triggers: flap-to-reference ratioFrom start of INVOS measurements (day 0) until day 3 postoperativeFlap-to-reference ratio of \<0.75. Yes/no
SecondaryIncidence sensor displacement or detachmentFrom day of surgery (day 0) until day 3 posteroperativeThe incidence of mechanical sensor displacement or complete detachment requiring clinical intervention or sensor replacement within the first 48 hours postoperatively.
SecondaryCumulative duration missing StO2 dataFrom start INVOS measurement (day 0) until day 3 postoperative
The cumulative duration of missing or uninterpretable tissue oxygen saturation (StO₂) data due to sensor detachment, signal artifacts, or hardware failure, expressed as a percentage (%) of the total monitoring time.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers6

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
19387157BACKGROUNDPubMed
22131106BACKGROUNDPubMed
29175135BACKGROUNDPubMed
29672776BACKGROUNDPubMed
32701027BACKGROUNDPubMed
34033637BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07887256

GET https://conductscience.org/api/trials/v1/NCT07887256/registered